The insider buying is small but directionally positive as both CEO and CFO are adding shares after a dilutive ATM facility. Monitor for pipeline updates or clinical catalysts that could explain the confidence. The ATM overhang remains a risk, but insider accumulation suggests management sees current valuation as attractive.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 2 $22.92entry
- T+1 · 4mo ago +6.85%α +5.98% · $24.49
- T+5 · 4mo ago +41.97%α +41.04% · $32.54
- T+20 · 4mo ago +25.74%α +26.16% · $28.82
- T+60 · 7w ago +26.75%α +23.74% · $29.05
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Anand Parikh and CFO Brian Stephenson made open-market purchases totaling ~$235K over a 10-day window, following the company's June 18 ATM offering of up to $150M. The buying is small relative to FTH's $644M market cap (0.04%) but notable as both top executives are buying after a dilutive facility.
Key Financial Metrics
Key Facts
- CEO Anand Parikh bought 2,800 shares at $19.76 on June 22 for ~$55K
- CFO Brian Stephenson made four purchases totaling 7,721 shares at $22.95-$23.61 for ~$180K between June 26 and July 1
- Total insider buying ~$235K, representing 0.04% of market cap
- Company filed an ATM offering (up to $150M) on June 18, 13 days before the cluster window ended
- Market cap: $644M; analyst consensus 80% bullish (8 Buy/4 Strong Buy, 2 Hold)
Financial Impact
Insider purchases of ~$235K are immaterial relative to $644M market cap
Risk Factors
- Dilution risk from the $150M ATM facility, which could pressure share price
- Early-stage biotech with no approved products or disclosed revenue
- Insider buying is too small to signal strong conviction; could be routine portfolio allocation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-FTH-1782951020281 |
Track record
12 reports on FTH
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +35.00% at T+60 after the Aug 11, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry price pending
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $10.03 Now $10.03 −0.00% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $10.03 −20.90% ▲ +1.89% +2.26% vs SPY
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $10.03 −20.90% ▲ +1.89% +2.26% vs SPY
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $19.65 to $19.99 Now $10.03 −48.96% ▲ +1.73% +0.08% vs SPY
- Oct 27, 202620d ago 3 Neutral 2/10 Entry $19.20 to $18.75 Now $10.03 −47.76% ▼ −2.34% −1.96% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $19.11 to $19.20 Now $10.03 −47.51% ▲ +0.47% +0.13% vs SPY
- Sep 15, 20268w ago 3 Neutral 2/10 Entry $34.24 to $35.13 Now $10.03 −70.71% ▲ +2.60% +1.47% vs SPY
- Aug 11, 202613w ago 144 Bearish 5/10 Entry $30.00 to $29.38 Now $10.03 +66.57% ▲ +2.07% +2.32% vs SPY
- Aug 4, 202614w ago 8-K Neutral 3/10 Entry $25.50 to $24.59 Now $10.03 −60.67% ▼ −3.57% −3.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers